Publicaciones en las que colabora con IRENE TERESA MOLINA MARTÍNEZ (57)

2024

  1. Enhancing the hypotensive effect of latanoprost by combining synthetic phosphatidylcholine liposomes with hyaluronic acid and osmoprotective agents

    Drug Delivery and Translational Research, Vol. 14, Núm. 10, pp. 2804-2822

2023

  1. A novel osmoprotective liposomal formulation from synthetic phospholipids to reduce in vitro hyperosmolar stress in dry eye treatments

    Journal of Liposome Research, Vol. 33, Núm. 2, pp. 117-128

  2. New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost

    Ocular Surface, Vol. 29, pp. 314-330

2022

  1. Development of an osmoprotective microemulsion as a therapeutic platform for ocular surface protection

    International Journal of Pharmaceutics, Vol. 623

  2. Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma Treatment

    Pharmaceutics, Vol. 14, Núm. 7

  3. Validation of a Rapid and Easy-to-Apply Method to Simultaneously Quantify Co-Loaded Dexamethasone and Melatonin PLGA Microspheres by HPLC-UV: Encapsulation Efficiency and In Vitro Release

    Pharmaceutics, Vol. 14, Núm. 2

2021

  1. A safe gdnf and gdnf/bdnf controlled delivery system improves migration in human retinal pigment epithelial cells and survival in retinal ganglion cells: Potential usefulness in degenerative retinal pathologies

    Pharmaceuticals, Vol. 14, Núm. 1, pp. 1-24

  2. Co-delivery of glial cell–derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseases

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 566-580

  3. Combined hyperosmolarity and inflammatory conditions in stressed human corneal epithelial cells and macrophages to evaluate osmoprotective agents as potential DED treatments

    Experimental Eye Research, Vol. 211

  4. Dexamethasone PLGA Microspheres for Sub-Tenon Administration: Influence of Sterilization and Tolerance Studies

    Pharmaceutics, Vol. 13, Núm. 2, pp. 228

  5. Dexamethasone plga microspheres for sub-tenon administration: Influence of sterilization and tolerance studies

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-21

  6. Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection

    Expert Opinion on Drug Delivery, Vol. 18, Núm. 7, pp. 819-847

  7. Microparticle Products for the Eye: Preformulation, Formulation, and Manufacturing Considerations

    AAPS Advances in the Pharmaceutical Sciences Series (Springer), pp. 381-407

  8. Thermo-responsive PLGA-PEG-PLGA hydrogels as novel injectable platforms for neuroprotective combined therapies in the treatment of retinal degenerative diseases

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-23

2020

  1. Gelatin nanoparticles-HPMC hybrid system for effective ocular topical administration of antihypertensive agents

    Pharmaceutics, Vol. 12, Núm. 4

  2. Trojan microparticles potential for ophthalmic drug delivery

    Current Medicinal Chemistry, Vol. 27, Núm. 4, pp. 570-582

2019

  1. Amphiphilic acrylic nanoparticles containing the poloxamer star Bayfit®10WF15 as ophthalmic drug carriers

    Polymers, Vol. 11, Núm. 7

  2. CHAPTER 10: Drug Delivery Systems for the Treatment of Diseases Affecting the Retina and Optic Nerve

    RSC Drug Discovery Series, Vol. 2019-January, Núm. 66, pp. 164-178

  3. Osmoprotectants in hybrid liposome/HPMC systems as potential glaucoma treatment

    Polymers, Vol. 11, Núm. 6

  4. Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma

    Journal of Controlled Release, Vol. 297, pp. 26-38